Avaliação da dose glandular média (MGD) em três sistemas mamográficos

Este estudo tem por objectivos determinar a Dose Glandular Média - Mean Glandular Dose (MGD) - em 3 sistemas de Mamografia e comparar os valores obtidos com os referenciais internacionais. O estudo foi realizado num sistema analógico de Écran-Película (EP) e em dois sistemas de imagem digital (CR e DR). Foi efectuado o cálculo da Entrance Surface Air Kerma (ESAK) e da MGD em três equipamentos a partir de uma amostra de dados referentes a 30 mulheres assintomáticas, com idades compreendidas entre os 40 e 64 anos. Em cada equipamento objecto de análise, foram recolhidos os dados referentes a 10 mulheres. Foram consideradas as projecções crânio-caudal (CC) e oblíqua médio-lateral (MLO). A análise de resultados revelou que o valor de MGD varia quando se compara os três sistemas. Nas incidências CC os valores de MGD obtidos foram de 1,54 mGy (EP), 1,78 mGy (CR) e 0,82 mGy (DR). Nas incidências MLO o valor de MGD foi de 1,53 mGy no sistema EP, de 1,78 mGy no CR e 0,87 mGy no sistema DR. Constata-se que o valor de MGD na incidência de CC é inferior ao valor de MGD na incidência MLO, excepto para o sistema EP. Verifica-se também que o sistema EP apresenta maior variabilidade nos dados de MGD comparativamente com os restantes sistemas. O sistema DR é o que apresenta a menor variabilidade de valores MGD e também valores de MGD mais baixos. Comparando os resultados deste estudo com as referências internacionais, verifica-se que a MGD se encontra abaixo do limite de 2 mGy recomendado. ABSTRACT - This study aims to estimate the Mean Glandular Dose (MGD) associated with three different mammographic systems and compare the results with recommended international reference values. The systems included in the study included a conventional Screen-Film (SF) system and two digital mammography systems (CR and DR). Entrance Surface Air Kerma (ESAK) and MGD associated with each equipment were calculated. A sample of 30 healthy women (age ranging from 40 to 64 years old) undertaking screening mammography was considered in this study. The mammographic exam includes two projections, cranio-caudal (CC) and medio-lateral oblique (MLO). The MGD results obtained for CC projection were 1,54 mGy (SF), 1,78 mGy (CR) and 0,82 mGy (DR). MGD values for the MLO projection were 1,53 mGy (SF), 1,78 mGy (CR) and 0,87 mGy (DR). Results show that MGD value is slightly lower in the CC projection than in MLO, except for the SF system (1,54 mGy; 1,53 mGy). In addition the MGD for the SF system varied more than that associated with the digital systems. The DR system allows a narrow variation of MGD values and also lower MGD values. Comparing this study results with the international references we concluded that MGD values are below the 2 mGy recommended value for the three systems evaluated.

Otimização de dose em mamografia

Mestrado em Radiações Aplicadas às Tecnologias da Saúde. Área de especialização: Imagem Digital com Radiação X.

Proteção radiológica em mamografia

Mestrado em Radiações Aplicadas às Tecnologias da Saúde. Área de especialização: Proteção contra Radiações.

Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types

Background: There are now several lines of evidence to suggest that protein synthesis and translation factors are involved in the regulation of cell proliferation and cancer development. Aims: To investigate gene expression patterns of eukaryotic releasing factor 3 (eRF3) in gastric cancer. Methods: RNA was prepared from 25 gastric tumour biopsies and adjacent non-neoplastic mucosa. Real time TaqMan reverse transcription polymerase chain reaction (RT-PCR) was performed to measure the relative gene expression levels. DNA was isolated from tumour and normal tissues and gene dosage was determined by a quantitative real time PCR using SYBR Green dye. Results: Different histological types of gastric tumours were analysed and nine of the 25 tumours revealed eRF3/GSPT1 overexpression; moreover, eight of the 12 intestinal type carcinomas analysed overexpressed the gene, whereas eRF3/GSPT1 was overexpressed in only one of the 10 diffuse type carcinomas (Kruskal-Wallis Test; p , 0.05). No correlation was found between ploidy and transcript expression levels of eRF3/GSPT1. Overexpression of eRF3/GSPT1 was not associated with increased translation rates because the upregulation of eRF3/GSPT1 did not correlate with increased eRF1 levels. Conclusions: Overexpression of eRF3/GSPT1 in intestinal type gastric tumours may lead to an increase in the translation efficiency of specific oncogenic transcripts. Alternatively, eRF3/GSPT1 may be involved in tumorigenesis as a result of its non-translational roles, namely (dis)regulating the cell cycle, apoptosis, or transcription.

Translation termination and protein folding pathway genes are not correlated in gastric cancer

Background: The eukaryotic release factor 3 (eRF3) has been shown to affect both tubulin and actin cytoskeleton, suggesting a role in cytoskeleton assembly, mitotic spindle formation and chromosome segregation. Also, direct interactions between eRF3 and subunits of the cytosolic chaperonin CCT have been described. Moreover, both eRF3a and CCT subunits have been described to be up-regulated in cancer tissues. Our aim was to evaluate the hypothesis that eRF3 expression levels are correlated with the expression of genes encoding proteins involved in the tubulin folding pathways. Methods: Relative expression levels of eRF1, eRF3a/GSPT1, PFDN4, CCT2, CCT4, and TBCA genes in tumour samples relative to their adjacent normal tissues were investigated using real time-polymerase chain reaction in 20 gastric cancer patients. Results: The expression levels of eRF3a/GSPT1 were not correlated with the expression levels of the other genes studied. However, significant correlations were detected between the other genes, both within intestinal and diffuse type tumours. Conclusions: eRF3a/GSPT1 expression at the mRNA level is independent from both cell translation rates and from the expression of the genes involved in tubulin-folding pathways. The differences in the patterns of expression of the genes studied support the hypothesis of genetically independent pathways in the origin of intestinal and diffuse type gastric tumours.

Failure on clinical image quality criteria in digital mammography: how can radiographers do better?

Purpose: To assess image quality using PGMI (perfect, good, moderate, inadequate) scale in digital mammography examinations acquired in DR systems. Identify the main failures and propose corrective actions. Evaluate the most typical breast density. Methods and Materials: Clinical image quality criteria were evaluated considering mammograms acquired in 13 DR systems and classified according to PGMI scale using the criteria described in European Commission guidelines for radiographers. The breast density was assessed according to ACR recommendations. The data were collected on the acquisition system monitor to reproduce the daily practice of the radiographer. Results: The image quality criteria were evaluated in 3044 images. The criteria were fully achieved in 41% of the images that were classified as P (perfect), 31 % of the images were classified as M (moderate), 20% G (good) and 9% I (inadequate). The main cause of inadequate image quality was absence of all breast tissue in the image, skin folders in the pectoral muscle and in the infra-mammary angle. The higher number of failures occurred in MLO projections (809 out of 1022). The most represented (36%) breast type was type 2 (25-50% glandular tissue). Conclusion: Incorrect radiographic technique was frequently detected suggesting potential training needs and poor communication between the team members (radiographer and radiologists). Further correlations are necessary to identify the main causes for the failures, namely specific education and training in digital mammography and workload.